vs

Side-by-side financial comparison of Offerpad Solutions Inc. (OPAD) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Offerpad Solutions Inc. is the larger business by last-quarter revenue ($114.1M vs $76.4M, roughly 1.5× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs -34.5%). Offerpad Solutions Inc. produced more free cash flow last quarter ($65.7M vs $-12.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs -36.8%).

Offerpad Solutions Inc is a prominent U.S. proptech firm focused on simplifying residential real estate transactions. Operating under the iBuyer model, it purchases homes directly from sellers, conducts required renovations, and resells properties to buyers. It also provides supporting services including mortgage assistance, title services, and flexible moving options for clients across dozens of U.S. states.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

OPAD vs PRCT — Head-to-Head

Bigger by revenue
OPAD
OPAD
1.5× larger
OPAD
$114.1M
$76.4M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+46.5% gap
PRCT
11.9%
-34.5%
OPAD
More free cash flow
OPAD
OPAD
$77.9M more FCF
OPAD
$65.7M
$-12.2M
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
-36.8%
OPAD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPAD
OPAD
PRCT
PRCT
Revenue
$114.1M
$76.4M
Net Profit
$-29.8M
Gross Margin
7.0%
60.6%
Operating Margin
-40.6%
Net Margin
-39.1%
Revenue YoY
-34.5%
11.9%
Net Profit YoY
49.1%
-58.3%
EPS (diluted)
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPAD
OPAD
PRCT
PRCT
Q4 25
$114.1M
$76.4M
Q3 25
$132.7M
$83.3M
Q2 25
$160.3M
$79.2M
Q1 25
$160.7M
$69.2M
Q4 24
$174.3M
$68.2M
Q3 24
$208.1M
$58.4M
Q2 24
$251.1M
$53.4M
Q1 24
$285.4M
$44.5M
Net Profit
OPAD
OPAD
PRCT
PRCT
Q4 25
$-29.8M
Q3 25
$-11.6M
$-21.4M
Q2 25
$-10.9M
$-19.6M
Q1 25
$-15.1M
$-24.7M
Q4 24
$-17.3M
$-18.9M
Q3 24
$-13.5M
$-21.0M
Q2 24
$-13.8M
$-25.6M
Q1 24
$-17.5M
$-26.0M
Gross Margin
OPAD
OPAD
PRCT
PRCT
Q4 25
7.0%
60.6%
Q3 25
7.0%
64.8%
Q2 25
8.9%
65.4%
Q1 25
6.5%
63.9%
Q4 24
6.1%
64.0%
Q3 24
8.2%
63.2%
Q2 24
8.7%
59.0%
Q1 24
7.9%
56.2%
Operating Margin
OPAD
OPAD
PRCT
PRCT
Q4 25
-40.6%
Q3 25
-5.1%
-27.8%
Q2 25
-4.9%
-28.0%
Q1 25
-7.2%
-39.7%
Q4 24
-7.8%
-28.9%
Q3 24
-4.3%
-38.4%
Q2 24
-3.9%
-50.3%
Q1 24
-4.8%
-62.1%
Net Margin
OPAD
OPAD
PRCT
PRCT
Q4 25
-39.1%
Q3 25
-8.7%
-25.7%
Q2 25
-6.8%
-24.7%
Q1 25
-9.4%
-35.8%
Q4 24
-9.9%
-27.6%
Q3 24
-6.5%
-35.9%
Q2 24
-5.5%
-48.0%
Q1 24
-6.1%
-58.3%
EPS (diluted)
OPAD
OPAD
PRCT
PRCT
Q4 25
$-0.54
Q3 25
$-0.37
$-0.38
Q2 25
$-0.39
$-0.35
Q1 25
$-0.55
$-0.45
Q4 24
$-0.64
$-0.34
Q3 24
$-0.49
$-0.40
Q2 24
$-0.50
$-0.50
Q1 24
$-0.64
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPAD
OPAD
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$26.5M
$286.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$38.2M
$365.9M
Total Assets
$154.8M
$508.1M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPAD
OPAD
PRCT
PRCT
Q4 25
$26.5M
$286.5M
Q3 25
$31.0M
$294.3M
Q2 25
$22.6M
$302.7M
Q1 25
$30.8M
$316.2M
Q4 24
$43.0M
$333.7M
Q3 24
$48.5M
$196.8M
Q2 24
$56.9M
$214.1M
Q1 24
$68.5M
$225.6M
Total Debt
OPAD
OPAD
PRCT
PRCT
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
OPAD
OPAD
PRCT
PRCT
Q4 25
$38.2M
$365.9M
Q3 25
$39.9M
$380.3M
Q2 25
$24.5M
$385.8M
Q1 25
$34.2M
$389.2M
Q4 24
$47.7M
$402.2M
Q3 24
$64.7M
$241.2M
Q2 24
$77.6M
$251.8M
Q1 24
$88.1M
$264.0M
Total Assets
OPAD
OPAD
PRCT
PRCT
Q4 25
$154.8M
$508.1M
Q3 25
$223.5M
$511.5M
Q2 25
$268.0M
$513.1M
Q1 25
$274.5M
$519.4M
Q4 24
$313.1M
$534.0M
Q3 24
$338.5M
$374.1M
Q2 24
$406.6M
$374.4M
Q1 24
$369.7M
$382.9M
Debt / Equity
OPAD
OPAD
PRCT
PRCT
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPAD
OPAD
PRCT
PRCT
Operating Cash FlowLast quarter
$66.8M
$-10.3M
Free Cash FlowOCF − Capex
$65.7M
$-12.2M
FCF MarginFCF / Revenue
57.6%
-15.9%
Capex IntensityCapex / Revenue
0.9%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPAD
OPAD
PRCT
PRCT
Q4 25
$66.8M
$-10.3M
Q3 25
$40.0M
$-6.6M
Q2 25
$-13.5M
$-15.0M
Q1 25
$-10.2M
$-17.0M
Q4 24
$20.8M
$-32.4M
Q3 24
$39.6M
$-18.8M
Q2 24
$-54.4M
$-15.7M
Q1 24
$2.4M
$-32.3M
Free Cash Flow
OPAD
OPAD
PRCT
PRCT
Q4 25
$65.7M
$-12.2M
Q3 25
$-9.5M
Q2 25
$-13.6M
$-17.8M
Q1 25
$-11.2M
$-18.8M
Q4 24
$15.4M
$-33.6M
Q3 24
$38.7M
$-19.0M
Q2 24
$-54.4M
$-16.8M
Q1 24
$2.0M
$-34.2M
FCF Margin
OPAD
OPAD
PRCT
PRCT
Q4 25
57.6%
-15.9%
Q3 25
-11.4%
Q2 25
-8.5%
-22.5%
Q1 25
-7.0%
-27.2%
Q4 24
8.9%
-49.2%
Q3 24
18.6%
-32.6%
Q2 24
-21.7%
-31.4%
Q1 24
0.7%
-76.9%
Capex Intensity
OPAD
OPAD
PRCT
PRCT
Q4 25
0.9%
2.4%
Q3 25
0.0%
3.4%
Q2 25
0.1%
3.5%
Q1 25
0.6%
2.7%
Q4 24
3.1%
1.7%
Q3 24
0.4%
0.4%
Q2 24
0.0%
2.0%
Q1 24
0.1%
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPAD
OPAD

Segment breakdown not available.

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons